表紙
市場調査レポート

創傷被覆用フォーム:パイプライン製品の分析

Foams - Pipeline Review, 2015

発行 GlobalData 商品コード 333507
出版日 ページ情報 英文 36 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。
Back to Top
創傷被覆用フォーム:パイプライン製品の分析 Foams - Pipeline Review, 2015
出版日: 2015年05月25日 ページ情報: 英文 36 Pages
概要

当レポートでは、世界各国の企業・医療機関などで開発中の創傷被覆用フォーム (発泡体) のパイプライン製品情報について分析し、治験/製品開発の全体的な進行状況や、段階別・地域別・分野別の詳細動向、企業別・製品別の詳細情報 (治験の進行段階、開始/終了時期、認証見通しなど)、昨今の製品開発・資本取引の動きなどを盛り込んでお届けいたします。

第1章 目次

第2章 イントロダクション

  • 創傷被覆用フォーム (発泡体) の概要

第3章 開発中の製品

  • パイプライン製品:開発段階別
  • パイプライン製品:セグメント別
  • パイプライン製品:地域別
  • パイプライン製品:規制経路別
  • パイプライン製品:認証時期別 (推定)
  • 現在進行中の治験

第4章 創傷被覆用フォーム:開発中のパイプライン製品 (企業別)

  • 創傷被覆用フォームの開発企業:開発段階別のパイプライン製品
  • 創傷被覆用フォーム:開発段階別のパイプライン製品

第5章 創傷被覆用フォームの開発企業・製品の概要

  • Advanced Medical Solutions Group plc:企業概要
    • パイプライン製品および進行中の治験の概要
  • Genewel Co., Ltd:企業概要
  • Giltech Limited:企業概要
  • Medtric Biotech, LLC:企業概要
  • PolyNovo Biomaterials Pty Ltd:企業概要

第6章 創傷被覆用フォーム:昨今の市場動向

第7章 付録

図表一覧

目次
Product Code: GDME0021EPD

GlobalData's Medical Devices sector report, "Foams - Pipeline Review, 2015" provides an overview of Foams currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Foams pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Foams products under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Foams and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Foams under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Foams Overview

3. Products under Development

  • 3.1. Foams - Pipeline Products by Stage of Development
  • 3.2. Foams - Pipeline Products by Segment
  • 3.3. Foams - Pipeline Products by Territory
  • 3.4. Foams - Pipeline Products by Regulatory Path
  • 3.5. Foams - Pipeline Products by Estimated Approval Date
  • 3.6. Foams - Ongoing Clinical Trials

4. Foams - Pipeline Products under Development by Companies

  • 4.1. Foams Companies - Pipeline Products by Stage of Development
  • 4.2. Foams - Pipeline Products by Stage of Development

5. Foams Companies and Product Overview

  • 5.1. Advanced Medical Solutions Group plc Company Overview
    • 5.1.1. Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Genewel Co., Ltd Company Overview
    • 5.2.1. Genewel Co., Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Giltech Limited Company Overview
    • 5.3.1. Giltech Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Medtric Biotech, LLC Company Overview
    • 5.4.1. Medtric Biotech, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. PolyNovo Biomaterials Pty Ltd Company Overview
    • 5.5.1. PolyNovo Biomaterials Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview

6. Foams- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Foams - Pipeline Products by Stage of Development
  • Table 2: Foams - Pipeline Products by Segment
  • Table 3: Foams - Pipeline Products by Territory
  • Table 4: Foams - Pipeline Products by Regulatory Path
  • Table 5: Foams - Pipeline Products by Estimated Approval Date
  • Table 6: Foams - Ongoing Clinical Trials
  • Table 7: Foams Companies - Pipeline Products by Stage of Development
  • Table 8: Foams - Pipeline Products by Stage of Development
  • Table 9: Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: Anti-Microbial Foam Dressing - Product Status
  • Table 11: Anti-Microbial Foam Dressing - Product Description
  • Table 12: Atraumatic Foam Dressing - Product Status
  • Table 13: Atraumatic Foam Dressing - Product Description
  • Table 14: Genewel Co., Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 15: Medifoam - Product Status
  • Table 16: Medifoam - Product Description
  • Table 17: Giltech Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 18: Molvacor - Product Status
  • Table 19: Molvacor - Product Description
  • Table 20: Medtric Biotech, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: Osmotec - Foam Pad - Product Status
  • Table 22: Osmotec - Foam Pad - Product Description
  • Table 23: PolyNovo Biomaterials Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 24: Biodegradable Temporising Matrix - Burns - Product Status
  • Table 25: Biodegradable Temporising Matrix - Burns - Product Description
  • Table 26: Biodegradable Temporising Matrix - Surgical Wounds - Product Status
  • Table 27: Biodegradable Temporising Matrix - Surgical Wounds - Product Description
  • Table 28: PolyNovo Biomaterials Pty Ltd - Ongoing Clinical Trials Overview
  • Table 29: Biodegradable Temporising Matrix - Burns - Biodegradable Temporizing Matrix (BTM) in Dermal Replacement and Wound Temporization Prior to Definitive Split-skin Grafting Post-excision of Full Thickness Burns Affecting Between 20% and 50% of The Total Body Surface Area (TBSA) to Assess Integration, Delamination and Ability to Support Subsequent Graft Take
  • Table 30: Glossary

List of Figures

  • Figure 1: Foams - Pipeline Products by Stage of Development
  • Figure 2: Foams - Pipeline Products by Segment
  • Figure 3: Foams - Pipeline Products by Territory
  • Figure 4: Foams - Pipeline Products by Regulatory Path
  • Figure 5: Foams - Pipeline Products by Estimated Approval Date
  • Figure 6: Foams - Ongoing Clinical Trials
Back to Top